Two Sigma Advisers »

Revance Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-06-30 $28M 1.1M 25.31
2023-03-31 $50M 1.5M 32.21
2022-12-31 $22M 1.2M 18.46
2022-09-30 $14M 508k 27.00
2022-06-30 $1.5M 108k 13.82
2020-09-30 $1.6M 65k 25.14
2020-06-30 $1.5M 61k 24.43
2020-03-31 $734k 50k 14.80
2019-06-30 $215k 17k 12.95
2019-03-31 $571k 36k 15.77
2018-09-30 $472k 19k 24.84
2018-06-30 $1.1M 41k 27.45
2018-03-31 $687k 22k 30.81
2017-12-31 $343k 9.6k 35.73
2015-06-30 $313k 9.8k 31.94
2015-03-31 $549k 27k 20.72